CDC: Smoking Rates Declining

New data from the CDC indicate that smoking rates are on the decline and smokers are smoking less, but there’s still room for improvement. Medscape Medical News

Salt and Inactivity: A Recipe for Cognitive Decline

A new study suggests reducing sodium intake, especially in older physically inactive adults, might help preserve cognitive function, independent of hypertension. Medscape Medical News

Even Mild Cognitive Impairment Predicts Early Death

Researchers say that identifying mild cognitive impairment in routine primary care encounters should be given a “higher priority.” Medscape Medical News

Multiple Lifestyle Factors Contribute to Diabetes Risk

Multiple lifestyle factors reduced incident diabetes risk by as much as 80%, according to new National Institutes of Health-American Association of Retired Persons Diet and Health Study findings. Medscape Medical News

Medical Residents Still Want Better Work-Life Balance (CME/CE)

(MedPage Today) — Despite regulations that limit their work hours, one-third of U.S. medical residents who responded to a national survey were dissatisfied with their work-life balance and half of them had symptoms of burnout.

Gays, Lesbians Lose Out in Med School Curricula (CME/CE)

(MedPage Today) — Medical schools gave about five hours of classroom time to the healthcare needs of lesbian, gay, bisexual, and transgender patients, a survey revealed.

U.S. Smoking Rates Dropping Slowly (CME/CE)

(MedPage Today) — Smoking prevalence in the U.S. has fallen over the last five years, but not at a consistent rate, CDC researchers said.

Racial Bias Doesn’t Color Med Students’ Clinical Decisions (CME/CE, with video)

(MedPage Today) — Future physicians exhibited an implicit preference for white and upper-class individuals, but clinical assessments were unaffected, responses to a survey and vignettes that mimicked common physician-patient encounters showed.

Tickborne Disease May Threaten Blood Supply, CDC Says (CME/CE)

(MedPage Today) — Infections with Babesia protozoan parasites — normally a tickborne disease — from blood transfusions have escalated recently, suggesting that the blood supply is increasingly at risk for contamination, CDC researchers said.

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Teva Pharmaceutical Industries Ltd. and Alcobra Ltd. announced today top-line results from a six week, randomized, placebo-controlled, Phase II multi-center study designed to assess the safety and efficacy of MG01CI in adults with attention deficit hyperactivity disorder (ADHD).